India DNA Synthesis Market Research Report By Application (Gene Therapy, Synthetic Biology, Molecular Diagnostics, Vaccine Development), By Product Type (Oligonucleotides, Gene Fragments, Gene Libraries), By End User (Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Clinical Laboratories) and By Technology (Solid-Phase Synthesis, Liquid-Phase Synthesis, PCR-Based Synthesis)- Forecast to 2035

India DNA Synthesis Market Overview

As per MRFR analysis, the India DNA Synthesis Market Size was estimated at 265 (USD Million) in 2023. The India DNA Synthesis Market Industry is expected to grow from 289.38(USD Million) in 2024 to 823.12 (USD Million) by 2035. The India DNA Synthesis Market CAGR (growth rate) is expected to be around 9.97% during the forecast period (2025 - 2035)

Key India DNA Synthesis Market Trends Highlighted

The India DNA synthesis market is experiencing a transformation driven by several key market drivers. Increased investment in biotechnology and life sciences from both the government and private sectors is propelling this trend. The Indian government promotes research and development in genomics as part of its initiatives to enhance healthcare and agriculture through programs like the National Biotechnology Development Strategy. Furthermore, the growth of personalized medicine is fostering a demand for DNA synthesis services, as researchers and clinicians seek tailored treatment options. 

Opportunities abound in the field of synthetic biology and genomics in India, particularly in the agricultural sector, where genetic modifications can lead to higher-yielding crops and disease-resistant plants.This aligns with the government’s push for sustainable agriculture, making it a fertile ground for innovation in DNA synthesis techniques. In addition, the rising prevalence of genetic disorders has led to increased genomic research, thereby stimulating demand for DNA synthesis applications in diagnostics and therapeutics, representing a significant opportunity for growth in the market. 

In recent times, there has been a noticeable trend towards collaboration between academic institutions, research organizations, and industry players in India. These partnerships are fostering innovation and enhancing capabilities in DNA synthesis technology. Moreover, the awareness of bioethical considerations and regulatory frameworks surrounding genetic research is evolving, further shaping the market landscape.This collective momentum is positioning India as an emerging hub for advancements in DNA synthesis and biotechnology, promoting sustainable and impactful solutions for health and agriculture on both domestic and global fronts.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India DNA Synthesis Market Drivers

Increasing Research and Development Activities

The growing research and development (R&D) efforts in both the academic and commercial sectors are contributing to a notable uptick in the India DNA Synthesis Market Industry. The Indian government has been investing heavily in genomics and biotechnology; by 2025, the Department of Biotechnology intends to spend more than 23 billion Indian rupees on genetic engineering and genomics research and development. Additionally, Indian biotech companies have been pushed to do considerable in-house research and development by efforts such as the 'Make in India' campaign. 

Gene synthesis is receiving more attention from well-known institutions like the Indian Institute of Science and other biotechnology companies, which is boosting market innovation and capacity. This increased focus on research and development is essential since it results in more effective synthesis methods, which in turn fuel demand in the India DNA Synthesis Market.

Rising Applications in Healthcare and Personalized Medicine

The application of DNA synthesis technology in healthcare, particularly for personalized medicine, is significantly influencing the India DNA Synthesis Market Industry. With the prevalence of chronic diseases on the rise, as evidenced by the Indian Ministry of Health and Family Welfare reporting that non-communicable diseases account for about 62% of all deaths in India, there is an increasing need for tailored therapeutic solutions. 

Organizations like the Genome Valley in Hyderabad are actively conducting research on genomic medicine, ushering in innovative treatments that directly heighten the demand for synthesized DNA.The growing need for targeted therapies is making personalized medicine a pivotal segment, thereby propelling market growth in DNA synthesis.

Government Initiatives and Support for Biotechnology

Government support plays a vital role in the expansion of the India DNA Synthesis Market Industry. The Indian government has implemented various policies and schemes aimed at promoting biotechnology, such as the Biotech Policy and the establishment of Biotechnology Incubation Centers. These initiatives aim to create a robust infrastructure for biotech innovation, fostering an environment conducive to growth in DNA synthesis technologies. 

Additionally, the Biotechnology Industry Research Assistance Council provides funding support for projects that focus on genetic engineering, thereby incentivizing companies to invest in DNA synthesis.This strong backing promotes market stability and encourages advancements in the DNA synthesis process across the region.

Growing Biomedical and Agricultural Biotechnology Applications

The application of DNA synthesis in both biomedical and agricultural biotechnology is a major driver for the India DNA Synthesis Market Industry. With the Agricultural and Processed Food Products Export Development Authority noting an increase in demand for genetically modified crops, there is a marked rise in the need for efficient DNA synthesis technologies to improve crop resilience and yield. 

Additionally, advancements in synthetic biology are leading to innovative solutions in disease management and pharmaceuticals.Major agricultural firms in India are adopting DNA synthesis services for crop improvement programs, thereby expanding the market's reach and applications. This growing intersection of technology and agriculture further amplifies the potential of the India DNA Synthesis Market Industry.

India DNA Synthesis Market Segment Insights

DNA Synthesis Market Application Insights

The Application segment of the India DNA Synthesis Market showcases a dynamic landscape driven by advancements in biotechnology and increasing demand for innovative solutions in healthcare. The Gene Therapy domain is gaining traction due to its potential to treat genetic disorders, offering new therapeutic avenues. This is particularly significant in India, where genetic diseases pose a substantial public health challenge, and ongoing research is being bolstered by government initiatives such as the National Biotechnology Development Strategy. 

Synthetic Biology stands out as another critical area, contributing to the development of bio-based products and sustainable practices, aligning with global goals of environmental sustainability and food security.The focus on engineering biological systems presents lucrative opportunities for industries ranging from agriculture to pharmaceuticals. Molecular Diagnostics is becoming increasingly vital in India, especially in the context of personalized medicine. This segment allows for precise disease detection and treatment planning, addressing the healthcare needs of a growing population. 

Moreover, the COVID-19 pandemic has accelerated investments in molecular diagnostics, highlighting the importance of rapid and accurate testing methods. Vaccine Development remains a pivotal application within the market, with India being a global hub for vaccine research and manufacturing.The country’s extensive experience in vaccine production positions it as a leader in the development of both traditional and mRNA vaccines, reflecting its capability to respond swiftly to public health needs. Overall, the Application segment is characterized by a robust interplay of innovation and necessity, reflecting India's dedication to enhancing its biotechnology capabilities while addressing significant health challenges. 

The collective growth in these areas not only signifies the potential for economic growth but also portrays a commitment to improving health outcomes across the nation.As a result, the India DNA Synthesis Market exhibits a diverse and evolving landscape that is set to play a pivotal role in future biotechnological advancements.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

DNA Synthesis Market Product Type Insights

The India DNA Synthesis Market encompasses several vital product types, with Oligonucleotides, Gene Fragments, and Gene Libraries playing essential roles in the growth of the industry. Oligonucleotides are significant due to their application in various biotechnology and pharmaceutical sectors, driving research and development in gene therapies and diagnostics. Gene Fragments contribute to advancements in synthetic biology and genomics, facilitating the construction of entire genes and complex pathways, which are crucial for personalized medicine and synthetic organisms.Gene Libraries serve as extensive resources for researchers to explore genetic variability and function, aiding in drug discovery and functional genomics. 

Together, these product types reflect a dynamic landscape where innovative technologies and scientific discoveries are advancing the capabilities of genetic research in India. The growth in these segments is also supported by increasing investment from the government and private sectors in biotechnology, alongside a rising demand for personalized healthcare solutions. This market's promising outlook demonstrates the integral role of these product types in shaping the future of genomics and biotechnology in India.

DNA Synthesis Market End User Insights

The India DNA Synthesis Market is significantly influenced by its End User landscape, which comprises Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories. Academic Research Institutions play a crucial role in driving innovations and enhancing scientific knowledge through advanced research initiatives, leading to a growing demand for DNA synthesis products. Pharmaceutical Companies leverage these services for drug development and genomic studies, promoting the integration of DNA synthesis in therapeutic applications, thus expanding their research capabilities.

Biotechnology Companies contribute to the market by focusing on synthetic biology and genetic engineering, where DNA synthesis is essential for developing new products and solutions. Clinical Laboratories utilize DNA synthesis for diagnostics, personalized medicine, and genetic testing, ensuring that patient care is tailored and effective. As the India DNA Synthesis Market evolves, these End Users are essential to harnessing advancements in genetic research, ultimately pushing the industry towards greater heights in innovation and application, reflecting an overall growth trend within the sector.

DNA Synthesis Market Technology Insights

The India DNA Synthesis Market, particularly within the Technology segment, is evolving rapidly as advancements in molecular biology and genomics drive growth in this field. Solid-Phase Synthesis has emerged as a prominent method due to its efficiency and scalability, enabling reliable production of oligonucleotides for various applications, including therapeutics and Research and Development. Liquid-Phase Synthesis presents alternative benefits as it often allows for more flexibility in reaction conditions, becoming significant for specific biochemical assays and research applications.

Additionally, PCR-Based Synthesis plays a crucial role as a widely adopted technique that enhances the accessibility and practicality of DNA synthesis in laboratories across India. The increasing focus on personalized medicine and rising investments in biotechnology are strengthening the relevance of these technologies, reinforcing the segmentation within the India DNA Synthesis Market. The collective influence of these methodologies demonstrates their integral role in expanding the overall industry, catering to diverse needs ranging from diagnostics to therapeutic developments in the country.

India DNA Synthesis Market Key Players and Competitive Insights

The India DNA Synthesis Market has emerged as a rapidly evolving sector within the biotechnology landscape, characterized by dynamic competition and an influx of innovative technologies. As the demand for synthetic DNA rises across various applications such as genomics, diagnostics, and therapeutic development, numerous firms have ventured into this domain. Key players in this market are continuously enhancing their capabilities through technological advancements, strategic collaborations, and the development of comprehensive service offerings. The growing investment in research and development, particularly in genomics and synthetic biology, further intensifies competition among market participants. 

With the expanding biotechnology ecosystem in India, understanding the competitive insights provides invaluable information for stakeholders looking to navigate this promising yet complex environment.Twist Bioscience has established a significant presence in the India DNA Synthesis Market with its advanced synthetic DNA platform, which is based on a unique silicon-based DNA synthesis technology. This innovative approach allows for high-quality, high-throughput synthesis of DNA, making Twist Bioscience a strong competitor in the field. The company has fortified its position by offering services that cater to a variety of applications, including gene synthesis, oligonucleotide production, and libraries for drug discovery and development. 

The ability of Twist Bioscience to capture and efficiently meet the diverse needs of customers in India has contributed to its reputation as a reliable partner in biotechnology. Moreover, its commitment to maintaining high-quality standards and rapid turnaround times further enhances its attractiveness in the market.GenScript has established itself as a prominent player in the India DNA Synthesis Market, providing a comprehensive range of products and services that cater to researchers and organizations involved in genetic research and biotechnology. The company specializes in gene synthesis, peptide synthesis, and antibody services, thus offering a well-rounded portfolio to its customers. GenScript's strengths lie in its robust production capabilities and commitment to quality, which allow for the reliable synthesis of complex DNA sequences tailored to specific research needs. 

The company's strategic moves in expanding its presence in India demonstrate its focus on leveraging local market opportunities. GenScript has also engaged in various collaborations and partnerships to enhance its service offerings in India, positioning itself as a key player in the biotechnology supply chain. Its emphasis on customer-centric solutions and technological advancements ensures that GenScript remains competitive in the evolving landscape of DNA synthesis within the region.

Key Companies in the India DNA Synthesis Market Include

• Twist Bioscience


• GenScript


• DNA2.0


• Bharat Biotech


• SigmaAldrich


• Integrated DNA Technologies


• Hera BioLabs


• Eurofins Scientific


• Biocon


• Strand Life Sciences


• Thermo Fisher Scientific


• Molecular Devices


• Agilent Technologies


• Bioneer


• Primetech

India DNA Synthesis Market Industry Developments

The India DNA Synthesis Market has witnessed significant developments recently, particularly with companies like Twist Bioscience and GenScript leading advancements in synthetic biology. In October 2023, DNA2.0 announced a partnership with Bharat Biotech to enhance vaccine development processes, reflecting the growing collaboration within the biotechnology sector. Also, SigmaAldrich has expanded its product offerings in India, catering to the increasing demand for synthetic DNA solutions. Integrated DNA Technologies and Hera BioLabs have recently invested in new facilities to scale up their operations in India, anticipating a surge in demand for synthetic genes and oligonucleotides. 

Furthermore, in August 2023, Thermo Fisher Scientific opened a new distribution center in India to streamline its supply chain for reagents and consumables. The market is projected to experience a robust growth trajectory, bolstered by the rise of biotechnology research initiatives supported by Indian government policies. Recent trends indicate that key players like Biocon and Strand Life Sciences are also focusing on research and development, which is expected to further escalate market valuation. Over the past two to three years, the sector has expanded due to increased investment in genomics and personalized medicine in India.

India DNA Synthesis Market Segmentation Insights

• 
  DNA Synthesis Market Application Outlook
  
  
  
  • Gene Therapy
  
  
  
  
  • Synthetic Biology
  
  
  • Molecular Diagnostics
  
  
  • Vaccine Development
  
  


• 
  DNA Synthesis Market Product Type Outlook
  
  
  
  • Oligonucleotides
  
  
  
  
  • Gene Fragments
  
  
  • Gene Libraries
  
  


• 
  DNA Synthesis Market End User Outlook
  
  
  
  • Academic Research Institutions
  
  
  
  
  • Pharmaceutical Companies
  
  
  • Biotechnology Companies
  
  
  • Clinical Laboratories
  
  


• 
  DNA Synthesis Market Technology Outlook
  
  
  
  • Solid-Phase Synthesis
  
  
  
  
  • Liquid-Phase Synthesis
  
  
  • PCR-Based Synthesis
  
  

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	265.0(USD Million)
MARKET SIZE 2024	289.38(USD Million)
MARKET SIZE 2035	823.12(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.97% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Twist Bioscience, GenScript, DNA2.0, Bharat Biotech, SigmaAldrich, Integrated DNA Technologies, Hera BioLabs, Eurofins Scientific, Biocon, Strand Life Sciences, Thermo Fisher Scientific, Molecular Devices, Agilent Technologies, Bioneer, Primetech
SEGMENTS COVERED	Application, Product Type, End User, Technology
KEY MARKET OPPORTUNITIES	Biotechnology R&D expansion, Personalized medicine developments, Agricultural genomics advancements, Affordable synthesis technologies, Synthetic biology innovations
KEY MARKET DYNAMICS	Rising demand for synthetic biology, Growth in biotechnology research, Advancements in DNA synthesis technology, Increasing applications in genomics, Supportive government initiatives and policies
COUNTRIES COVERED	India